An in vivo safety and efficacy demonstration of a topical liposomal nitric oxide donor treatment for Staphylococcus aureus biofilm-associated rhinosinusitis.
about
Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms.Lipid-based carriers for controlled delivery of nitric oxide.Hyaluronate effect on bacterial biofilm in ENT district infections: a review.Targeting microbial biofilms: current and prospective therapeutic strategies.Animal Models in CRS and Pathophysiologic Insights Gained: A Systematic Review.Modelling upper respiratory tract diseases: getting grips on host-microbe interactions in chronic rhinosinusitis using in vitro technologies.
P2860
An in vivo safety and efficacy demonstration of a topical liposomal nitric oxide donor treatment for Staphylococcus aureus biofilm-associated rhinosinusitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
An in vivo safety and efficacy ...... ilm-associated rhinosinusitis.
@en
type
label
An in vivo safety and efficacy ...... ilm-associated rhinosinusitis.
@en
prefLabel
An in vivo safety and efficacy ...... ilm-associated rhinosinusitis.
@en
P2093
P50
P1476
An in vivo safety and efficacy ...... ilm-associated rhinosinusitis.
@en
P2093
Amanda Drilling
Camille Jardeleza
Clive A Prestidge
Craig James
Dijana Miljkovic
Sathish Paramasivan
Shasha Rao
Sukanya Rajiv
P304
P356
10.1016/J.TRSL.2015.06.009
P577
2015-06-24T00:00:00Z